J. D. de Graaf

The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditions

G. Groenewegen, A. Griffioen, S. Martinotti, 2004, Angiogenesis.

Nitric Oxide Functions as an Inhibitor of Platelet Adhesion Under Flow Conditions

J. Sixma, S. Moncada, R. Palmer, 1992, Circulation.

Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet and Vessel Wall Interaction in NIDDM

J. Sixma, J. Akkerman, J. Banga, 1993, Diabetes Care.

Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study

J. D. de Groot, J. D. de Graaf, W. Coers, 2016, Drugs in R&D.

Avoiding Unnecessary Major Rectal Cancer Surgery by Implementing Structural Restaging and a Watch-and-Wait Strategy After Neoadjuvant Radiochemotherapy

G. Beets, O. Reerink, H. L. van Westreenen, 2020, Annals of Surgical Oncology.

Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study.

E. D. de Vries, S. Siesling, J. E. Boers, 2014, European journal of cancer.

Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: a population-based study focusing on the elderly

S. Siesling, J. E. Boers, F. Jansman, 2016, Anti-cancer drugs.

Assessing the clinical significance of drug interactions with fluorouracil in patients with colorectal cancer.

W. M. Smit, D. Sleijfer, J. Brouwers, 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Platelet Adhesion to Subendothelial Structures under Flow Conditions: No Effect of the Lipoxygenase Product 13-HODE

J. Sixma, P. D. de Groot, G. D. De Meyer, 1989, Thrombosis and Haemostasis.

Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study.

J. D. de Groot, P. Siersema, W. H. de Vos Tot Nederveen Cappel, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Classification and occurrence of clinically significant drug interactions with irinotecan and oxaliplatin in patients with metastatic colorectal cancer.

W. M. Smit, D. Sleijfer, J. Brouwers, 2005, Clinical therapeutics.